Tramadol Hydrochloride 50 mg Tablets by Amneal Pharmaceuticals
Key Features:
Dosage Strength: 50 mg per tablet
Quantity: 500 tablets per bottle
Manufacturer: Amneal Pharmaceuticals
Imprint Details: White, round, 9 mm tablet marked “AN 627”
Controlled Substance Classification: Schedule IV (C-IV) – potential for abuse and dependence
Description
Tramadol HCl 50mg Tablets by Amneal are a prescription medication used to manage moderate to moderately severe pain in adults. As a synthetic opioid analgesic, Tramadol works by altering the way the brain and nervous system respond to pain. This medication is classified as a Schedule IV controlled substance due to its potential for abuse, dependence, and addiction. It is often prescribed for conditions such as chronic pain, post-surgical pain, or pain from injury.
The 50mg strength is ideal for patients requiring consistent pain relief throughout the day. The 500-tablet supply offers a convenient, long-lasting option for both patients and healthcare providers. These tablets are designed for oral administration, providing effective pain management with minimal gastrointestinal side effects when taken as directed.
Key Features:
Strength: 50mg per tablet, providing effective pain relief for moderate pain
Controlled Substance: Schedule IV (C4) medication with a potential for abuse and dependence
Formulation: Oral tablets that are easy to administer and suitable for daily use
Packaging: 500 tablets per bottle, offering an extended supply for long-term treatment
Mechanism of Action: Works by altering pain perception in the brain, providing effective pain management
Indication: Used for moderate to moderately severe pain relief in adults
Safety: Only available with a prescription, ensuring proper usage and monitoring by a healthcare provider
Side Effects: Common side effects may include dizziness, nausea, and constipation; use under medical supervision is advised
Dosage: Should be taken as prescribed by a healthcare provider to avoid overdose or misuse

Reviews
There are no reviews yet.